Top Markets
Coin of the day
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Rank in Stocks #6695
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jรถrgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgรฅrd Schambye, its corporate operations are based in Boston, Massachusetts.
Share Price
$30.90
Market Cap
$1.90B
Change (1 day)
1.68%
Change (1 year)
819.64%
Country
US
Trade Damora Therapeutics, Inc. (DMRA)

Category

Stock price history for Damora Therapeutics, Inc. (DMRA)
Highest end of day price: $30.70 on 2026-08-01

Lowest end of day price: $375.00 on 2020-10-01
Stock price history of Damora Therapeutics, Inc. from 2020 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -19.21%
2025 415.83%
2024 -67.67%
2023 -52.57%
2022 -51.37%
2021 -80.02%
2020 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$548.36 40.94%
US
$1.06K 49.46%
NL
$122.63 -12.65%
AU
$140.81 461.00%
US
$765.25 7.19%
CH